Welcome to
RBP World!
Drugs target to SNCA
Drug name | Drug type | Disease/phenotype | Mechanism of action(MoA) | Phase | Status | Source |
---|---|---|---|---|---|---|
PRASINEZUMAB | Antibody | Parkinson disease | Alpha-synuclein binding agent | 2.0 | Active, not recruiting | ClinicalTrials |
CINPANEMAB | Antibody | Parkinson disease | Alpha-synuclein inhibitor | 2.0 | Terminated | ClinicalTrials |
PRASINEZUMAB | Antibody | Parkinson disease | Alpha-synuclein binding agent | 2.0 | Recruiting | ClinicalTrials |
CINPANEMAB | Antibody | Parkinson disease | Alpha-synuclein inhibitor | 1.0 | Terminated | ClinicalTrials |
PRASINEZUMAB | Antibody | Parkinson disease | Alpha-synuclein binding agent | 1.0 | Completed | ClinicalTrials |
CINPANEMAB | Antibody | Parkinson disease | Alpha-synuclein inhibitor | 1.0 | Completed | ClinicalTrials |